CD8A and neoplasm: In response to restimulation with the tumor-specific peptide, induction of the CD8+ T cell effector cytokine interferon gamma (IFN-γ) was greatly enhanced from splenocytes of CT26-bearing mice treated with an anti-TIGIT antibody with an intact Fc backbone (Figure 6C).